Metropolis OF BALIKPAPAN – The Food items and Drug Supervisory Company (BPOM) has granted the marketing and advertising authorization for vaccine Dengue under the name Qdenga, starting right now Friday 9 September 2022.
For your facts, Qdenga is vaccine with indications in the prevention of dengue disorder brought on by the dengue virus at the age of 6 to 45 yrs.
The vaccine is manufactured by IDT Biologika GmbH Germany. Then issued and registered on behalf of Takeda GmbH Germany.
The Qdenga vaccine is a vaccine Dengue according to permitted by BPOM article Dengvaxia (registered beneath the title of PT Aventis Pharma).
In accordance to BPOM, vaccine Qdenga is a sort of live attenuated tetravalent Dengue Vaccine (TDV) consisting of 4 viral strains Dengue.
Among the other issues, strains Dengue attenuated serotype 2 (TDV-2), recombinant pressure Dengue serotype 2/1 (TDV-1), recombinant strain Dengue serotype 2/3 (TDV-3).
Go through also: How to employ a healthy way of living, check out out these added benefits
And recombinant strain Dengue serotype 2/4 (TDV). -4).
In the meantime, vaccine TDV-2 pressure created by Virus Dengue form two attenuated (attenuated).
–
:strip_icc()/i.s3.glbimg.com/v1/AUTH_bc8228b6673f488aa253bbcb03c80ec5/internal_photos/bs/2022/7/E/ref7P6RlqpaHMMFBl7sA/agif22090416113650.jpg "In Cruzeiro Ronaldo indicates that the workforce has yet another sporting activities supplier: “There will be quite a few very good factors there” | cruise")
